Cl
Clinigen
Burton UKFounded 20101,000 employees
Private CappharmaAcquiredOncology
Platform: Managed Access
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Motanaritide | CLI-1058 | NDA/BLA | 2 | Aβ | Cervical CaAS | ||
| Mavulemzoparlimab | CLI-3551 | Phase 3 | 1 | FXIa | FSGSADHD |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (1)